29. Writing C, Steering Committee for the RCG, Algera AG, Pisani L, Serpa Neto A, den Boer SS, et al. Effect of a Lower vs Higher Positive End‐Expiratory Pressure Strategy on Ventilator‐Free Days in ICU Patients Without ARDS: A Randomized Clinical Trial. JAMA. 2020;324(24):2509‐20 https://doi.org/10.1001/jama.2020.23517. 30. Hopmans TEM, Smid EA, Wille JC, van der Kooi TII, Koek MBG, Vos MC, et al. Trends in prevalence of healthcare‐associated infections and antimicrobial use in hospitals in the Netherlands: 10 years of national point‐prevalence surveys. J Hosp Infect. 2019 https://doi.org/10.1016/j.jhin.2019.10.005. 31. PREZIES (Dutch national surveillance network for healthcare associated infections). PREZIES reference data Prevalence survey upto and including 2020. 2021 [Available from: https://www.rivm.nl/documenten/prezies‐referentiecijfers‐po‐tm‐2020. 32. PREZIES (Dutch national surveillance network for healthcare associated infections). Reference figures CRBSI surveillance, 2015‐2019 2021 [Available from: https://www.rivm.nl/documenten/referentiecijfers‐ lijnsepsis‐2019. 33. Ripa M, Galli L, Poli A, Oltolini C, Spagnuolo V, Mastrangelo A, et al. Secondary infections in patients hospitalized with COVID‐19: incidence and predictive factors. Clin Microbiol Infect. 2021;27(3):451‐7 https://doi.org/10.1016/j.cmi.2020.10.021. 34. Weiner‐Lastinger LM, Pattabiraman V, Konnor RY, Patel PR, Wong E, Xu SY, et al. The impact of coronavirus disease 2019 (COVID‐19) on healthcare‐associated infections in 2020: A summary of data reported to the National Healthcare Safety Network. Infect Control Hosp Epidemiol. 2022;43(1):12‐25 https://doi.org/10.1017/ice.2021.362. 35. Engsbro AL, Israelsen SB, Pedersen M, Tingsgaard S, Lisby G, Andersen CO, Benfield T. Predominance of hospital‐acquired bloodstream infection in patients with Covid‐19 pneumonia. Infect Dis (Lond). 2020;52(12):919‐22 https://doi.org/10.1080/23744235.2020.1802062. 36. Verberk JDM, van der Kooi TII, Kampstra NA, Reimes N, van Rooden SM, Hopmans TEM, et al. Healthcare‐associated infections in Dutch hospitals during the COVID‐19 pandemic. Antimicrob Resist Infect Control. 2023;12(1):2 https://doi.org/10.1186/s13756‐022‐01201‐z. 37. Meynaar IA, van Rijn S, Ottens TH, van Burgel ND, van Nieuwkoop C. Increased risk of central line‐ associated bloodstream infection in COVID‐19 patients associated with dexamethasone but not with interleukin antagonists. Intensive Care Med. 2022;48(7):954‐7 https://doi.org/10.1007/s00134‐022‐06750‐ w. 38. Van der Kooi T, Altorf-van der Kuil W, Schoffelen A, van Rooden S, de Greeff S, on behalf of the ISIS-AR study group. First COVID-19 wave in Dutch hospitals: effects on central venous catheter care and distribution of bacteremia pathogens (Abstract of the 6th International Conference on Prevention and Infection Control (ICPIC)). Antimicrob Resist Infect Control. 2021;10(1). 39. Lopez‐de‐Andres A, Lopez‐Herranz M, Hernandez‐Barrera V, de‐Miguel‐Diez J, de‐Miguel‐Yanes JM, Carabantes‐Alarcon D, et al. Sex Differences in Hospital‐Acquired Pneumonia among Patients with Type 2 Diabetes Mellitus Patients: Retrospective Cohort Study using Hospital Discharge Data in Spain (2016‐2019). Int J Environ Res Public Health. 2021;18(23) https://doi.org/10.3390/ijerph182312645. 40. Daniels KR, Lee GC, Frei CR. Trends in catheter‐associated urinary tract infections among a national cohort of hospitalized adults, 2001‐2010. Am J Infect Control. 2014;42(1):17‐22 https://doi.org/10.1016/j.ajic.2013.06.026. 41. Vincitorio D, Barbadoro P, Pennacchietti L, Pellegrini I, David S, Ponzio E, Prospero E. Risk factors for catheter‐associated urinary tract infection in Italian elderly. Am J Infect Control. 2014;42(8):898‐901 https://doi.org/10.1016/j.ajic.2014.05.006. 254 Chapter 10
RkJQdWJsaXNoZXIy MTk4NDMw